Pharmosa Biopharm (ROCO:6875) FCF Margin %: -171.95% (As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

ROCO:6875 Pharmosa Biopharm Inc ROCO:6875
11 GF Score
Price NT$35.55
! 1 Warning Sign
View Full Analysis

What is Pharmosa Biopharm FCF Margin %?

Pharmosa Biopharm ROCO:6875 +0.14% 11 FCF Margin % is -171.95% as of Dec. 2025. GuruFocus rates ROCO:6875 with a GF Score™ of 11/100. The stock has 1 warning sign investors should review. Among 950 Biotechnology companies, Pharmosa Biopharm ranks worse than 76.32% on this metric.

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. Pharmosa Biopharm's Free Cash Flow for the three months ended in Dec. 2025 was NT$-81.84 Mil. Pharmosa Biopharm's Revenue for the three months ended in Dec. 2025 was NT$47.59 Mil. Therefore, Pharmosa Biopharm's FCF Margin % for the quarter that ended in Dec. 2025 was -171.95%.

As of today, Pharmosa Biopharm's current FCF Yield % is -10.39%.

The historical rank and industry rank for Pharmosa Biopharm's FCF Margin % or its related term are showing as below:

ROCO:6875' s FCF Margin % Range Over the Past 10 Years
Min: -708.85   Med: -174.93   Max: -15.9
Current: -708.85

During the past 8 years, the highest FCF Margin % of Pharmosa Biopharm was -15.90%. The lowest was -708.85%. And the median was -174.93%.

ROCO:6875's FCF Margin % is ranked worse than
76.32% of 950 companies
in the Biotechnology industry
Industry Median: -81.28 vs ROCO:6875: -708.85

Pharmosa Biopharm FCF Margin % Related Terms

Pharmosa Biopharm FCF Margin % Historical Data

* Premium members only.

The historical data trend for Pharmosa Biopharm's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Pharmosa Biopharm FCF Margin % Chart

Pharmosa Biopharm Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
FCF Margin %
Get a 7-Day Free Trial 0.00 0.00 -15.90 -174.93 -708.85

Pharmosa Biopharm Quarterly Data
Dec18 Dec19 Dec20 Jun21 Dec21 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25
FCF Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 12.18 0.00 -894.51 -2,013.61 -171.95

ROCO:6875 vs VRTX, REGN, ALNY: FCF Margin % Comparison

For the Biotechnology subindustry, Pharmosa Biopharm's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Pharmosa Biopharm FCF Margin % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Pharmosa Biopharm's FCF Margin % distribution charts can be found below:

* The bar in red indicates where Pharmosa Biopharm's FCF Margin % falls into.


ROCO:6875
11GF Score
Pharmosa Biopharm Inc ROCO:6875
FCF Margin % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Pharmosa Biopharm FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

Pharmosa Biopharm's FCF Margin for the fiscal year that ended in Dec. 2025 is calculated as

FCF Margin=Free Cash Flow (A: Dec. 2025 )/Revenue (A: Dec. 2025 )
=-476.829/67.268
=-708.85 %

Pharmosa Biopharm's FCF Margin for the quarter that ended in Dec. 2025 is calculated as

FCF Margin=Free Cash Flow (Q: Dec. 2025 )/Revenue (Q: Dec. 2025 )
=-81.84/47.594
=-171.95 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about FCF Margin % →
What does a FCF Margin % of -171.95% mean?
Pharmosa Biopharm (ROCO:6875) has a FCF Margin % of -171.95% as of Dec. 2025. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Pharmosa Biopharm and its competitors. According to the industry distribution chart, Pharmosa Biopharm ranks #725 out of 950 companies in the Biotechnology industry, placing it in the top 76.3%.
Is Pharmosa Biopharm's FCF Margin % too high?
Pharmosa Biopharm's current FCF Margin % is -171.95%. Based on the distribution chart, Pharmosa Biopharm ranks #725 out of 950 companies in the Biotechnology industry, which is in the bottom quartile relative to peers. Overall, Pharmosa Biopharm has a GF Score™ of 11/100, reflecting its overall financial health beyond just this single metric.
How does Pharmosa Biopharm's FCF Margin % compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Pharmosa Biopharm ranks #725 out of 950 companies for FCF Margin %. This places Pharmosa Biopharm in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Margin % for a Biotechnology company?
A good FCF Margin % depends on the Biotechnology industry context. However, FCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Margin % mean?
A high FCF Margin % can signal that a stock is expensive relative to its fundamentals. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Pharmosa Biopharm and its competitors. Pharmosa Biopharm's current FCF Margin % is -171.95%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Pharmosa Biopharm stock overvalued right now?
Pharmosa Biopharm (ROCO:6875) has a current FCF Margin % of -171.95%. The current FCF Margin % is -171.95%. Pharmosa Biopharm's overall GF Score™ is 11/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Margin % calculated?
FCF Margin % is calculated from a company's financial statements. For Pharmosa Biopharm (ROCO:6875), the current FCF Margin % is -171.95% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Pharmosa Biopharm Business Description

Address No. 508, Sec. 7, Zhongxiao E. Road, 11th Floor / 11th Floor-1, Nangang District, Taipei, TWN
Pharmosa Biopharm Inc is a world-class biotechnology company. The Company's principal business activities comprise the development and commercialization of inventive biopharmaceutical drugs. Its product portfolio includes sustained-release dosage forms and drug-device combination products intended for home based therapies.
11GF Score

Get the complete analysis for ROCO:6875

FCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

NT$35.55
Price